Found 11 matching trials
Celecoxib With or Without Eflornithine in Preventing Colorectal Cancer in Patients With Familial Adenomatous Polyposis
PHASE2This randomized phase II trial studies how well giving celecoxib with or wi...
Location
M D Anderson Cancer Center
Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or Astrocytoma
PHASE1The purpose of this study is to establish the recommended phase 2 dose of e...
Location
University of Alabama at Birmingham
Neuroblastoma Maintenance Therapy Trial
PHASE2Difluoromethylornithine (DFMO) will be used in an open label, single agent,...
Status
Active Not Recruiting
Location
University of Alabama, Children's of Alabama
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
PHASE1This study will evaluate the safety, tolerability, and preliminary effectiv...
Location
University of Arizona
Oral AMXT 1501 Dicaprate in Combination With DFMO
PHASE1A Phase 1 study will be conducted to establish safety and dose level of AMX...
Location
Next Oncology - Austin Midtown
Safety Study for Refractory or Relapsed Neuroblastoma With DFMO Alone and in Combination With Etoposide
PHASE1The purpose of this research study is to evaluate a new investigational dru...
Location
Children's Hospital of Orange County
Targeting ODC as an Immunotherapeutic Target in STK11 (LKB1) Pathway-Deficient NSCLC (DFMO)
PHASE1The purpose of this study is to establish the safety, toxicity, and tolerab...
Location
Moffitt Cancer Center
DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
PHASE2Difluoromethylornithine (DFMO) will be used in an open label, multicenter, ...
Location
Arkansas Children's Hospital
Pivotal Study of Fexinidazole for Human African Trypanosomiasis in Stage 2
PHASE2This clinical trial is designed to prove the efficacy and safety of Fexinid...
DFMO Maintenance for Patients With Relapsed/Refractory Ewing Sarcoma or Osteosarcoma
PHASE1The purpose of this study is to determine the feasibility of administering ...
Location
Montefiore Medical Center